Ann: NYR-BI03 Phase Ia Clinical Trial Update 2, page-2

once this clears safety comping up and Walter Reed results coming up in next 2 weeks show any potential for TBI in the military it’s a formality this drug is well on its way to become a multi billion dollar drug class.

3 decades of proving up inhibiting calcium influx in the brain reduces brain injury but the issue was always that inhibiting Glutamate in animals was reducing brain injury but in humans it’s the opposite and because increasing glutamate not only damages the brain by increasing calcium influx but also is needed for the survival opposite to animals. NYR now have solved this issue. This will become a 100 million dollar plus company on safety clearance